Ansan, South Korea

Doo-Jin Kang

This inventor holds 1 USPTO granted patent. Top assignee: Ckd Bio Corp.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doo-Jin Kang. Retrieved from https://idiyas.com/inventor/doo-jin-kang-33nq9l4e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Doo-Jin Kang: Innovator in Pharmaceutical Processes

Introduction

Doo-Jin Kang is a notable inventor based in Ansan, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that enhance the efficiency and safety of drug production.

Latest Patents

Doo-Jin Kang holds a patent for a process titled "Process for preparing caspofungin and novel intermediates thereof." This invention relates to a novel method for preparing the aza cyclohexapeptide compound caspofungin, which is represented by a specific chemical formula. The process addresses issues related to pungent odor and toxicity, allowing for the production of caspofungin at a higher yield compared to traditional methods. He has 1 patent to his name.

Career Highlights

Doo-Jin Kang is currently employed at Ckd Bio Corp., where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug manufacturing processes, which is crucial for the development of effective medications.

Collaborations

He collaborates with talented colleagues, including Su-Hyun Kyong and Heung-Mo Kang, who contribute to the research and development efforts at Ckd Bio Corp.

Conclusion

Doo-Jin Kang's innovative work in pharmaceutical processes exemplifies the importance of advancements in drug production. His contributions are vital for improving the efficiency and safety of medications, ultimately benefiting the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…